Pacific Edge cuts losses by $4.7m on US growth

Pacific Edge cuts losses by $4.7m on US growth
Total lab throughput for tests dipped 6% compared to the prior year.
Brent Melville
Cancer diagnostics firm Pacific Edge has slowed its cash burn on the strength of key wins in its core US market, trimming net losses after tax by a quarter, or $4.7 million, to $14.2m for the year to March.That came off a more than doubling in revenue to $10.4m from a comparable $5.2m in 2020, with operating revenue from test sales at $7.7m, driven by inroads into the commercialisation of its Cxbladder product into international markets.Chief executive David Darling said the result had been achieved despite headwinds created by covid particular...

More Markets

RBNZ rate cut lifts sharemarket, high‑yield stocks climb
Markets Market Close

RBNZ rate cut lifts sharemarket, high‑yield stocks climb

The S&P/NZX 50 Index closed up 0.27% or 37.19 points.

ASB, IAG legal payouts prompt differing verdicts
Markets

ASB, IAG legal payouts prompt differing verdicts

ASB flagged the class action as a contingent liability.

Dairy prices fall for fourth straight auction, whole milk powder down 2.3%
Primary Sector

Dairy prices fall for fourth straight auction, whole milk powder down 2.3%

Prices have slipped again in the latest Global Dairy Trade auction, held overnight on Tuesday, with a 1.6% dip across the board.This was the fourth consecutive decline, following a 0.8% slide at the previous auction, a 4.3% decrease before that, and a 0.3% drop on Aug 19.Whole mi...

ANZ vows to fight CCCFA class action despite ASB settlement
Finance

ANZ vows to fight CCCFA class action despite ASB settlement

“ANZ NZ will continue to defend its case. Our position hasn’t changed.”